Cambridge Investment Research Advisors’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,061
Closed -$80K 3431
2024
Q1
$80K Buy
+10,061
New +$80K ﹤0.01% 3173